Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herbatrend is an herbal medicinal product developed by Penta Pharma, primarily used for the symptomatic relief of cough and respiratory congestion. The formulation is composed of natural botanical extracts, typically including Guava leaf (Psidium guajava), Tilia (Tilia cordata), and Fennel (Foeniculum vulgare). These components work synergistically to provide antitussive, mucolytic, and antispasmodic properties. Guava leaf is recognized for its ability to reduce cough frequency and intensity, Tilia provides a soothing effect on the throat and has mild sedative properties, and Fennel acts as an expectorant to help clear mucus from the airways. Herbatrend is generally marketed as a safe, natural alternative for managing upper respiratory tract infections and is available in oral dosage forms such as syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Herbatrend.